Colorado abandons controversial vaccine proposal; Germany puts down $28M for immunization in eastern Africa;

> The Colorado Senate passed a watered-down version of a bill that would have required parents to receive vaccine education before skipping out on their children's immunization. Story

> Germany has signed an agreement to provide €20 million ($27.6 million) to support immunization in eastern Africa. Report

> A researcher is recruiting Princeton students who received Novartis' ($NVS) not-yet-FDA-approved meningitis B shot Bexsero for a study on its impact. More

> Emergent BioSolutions' ($EBS) Biothrax anthrax jab has received the FDA's orphan drug designation for an indication in post-exposure prophylaxis. Release

> Immatics Biotechnologies GmbH's brain tumor candidate hit its primary endpoints in a Phase I trial. More

And Finally... An Australian doctor has set up a text-message system to monitor bad reactions to flu vaccines. Story

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.